Delivery Order 36F79719D0217-36C24523N0218
Award Date 12/6/22
Potential Completion Date 12/7/22
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for BALVERSA 4MG and has a period of performance through November 6, 2020. No set-aside provisions were applied to this award made to support the VA's healthcare programs. Janssen Biotech will provide the requested pharmaceutical...
- Janssen Biotech, Inc. was awarded a $15,754 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG tablets to be delivered to Carrollton, TX by July 26, 2022. No set-aside provisions were applied to this order placed under GSA Schedule contract FSS-61-IB. The delivery order provides BALVERSA oral chemotherapy tablets to...
- Janssen Biotech, Inc. was awarded a $15,754 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has a period of performance through August 19, 2022. No set-aside provisions were applied to this order placed under GSA Schedule contract FSS-61-IB. The delivery order will provide BALVERSA, a prescription oncology...
- Janssen Biotech, Inc. was awarded a $17,046.33 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has a period of performance through February 23, 2023. No set-aside provisions were applied to this award placed under GSA Schedule contract FSS-61-IB. The delivery order will provide needed pharmaceutical products to...
- Janssen Biotech, Inc. was awarded a $15,754.46 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has a period of performance through January 10, 2023. No set-aside provisions were applied to this order placed under GSA Schedule contract FSS-61-IB. The delivery order will supply the VA network with the cancer...
- Janssen Biotech, Inc. was awarded a $15,754 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has a period of performance through October 17, 2022. No set-aside provisions were applied to this award issued under GSA Schedule contract FSS-61-IB. The delivery order will provide BALVERSA, a prescription oncology...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. for BALVERSA 4 MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, a multiple award schedule managed by the General Services Administration. Performance will take place in Carrollton, Texas. No set-aside designation was used for this firm fixed price order, which is scheduled for completion by...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.88 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for BALVERSA 4 MG. The firm fixed price order is for the delivery of the specified pharmaceutical product to a location in Carrollton, Texas, with performance to be completed by November 13, 2020. No set-aside designation was applied to this order placed...
- Janssen Biotech, Inc. was awarded a $17,046.33 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has an anticipated completion date of April 6, 2023. No set-aside provisions were applied to this award issued under GSA Schedule contract FSS-61-IB. The place of performance will be Carrollton, TX 75010. This...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $11,317.97 delivery order to Janssen Biotech, Inc. for BALVERSA medication. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and performance period through December 31, 2021. No set-aside designation was applied. Janssen Biotech, Inc. will provide BALVERSA medication to support healthcare services for...